Estrogen regulation of gene expression in the brain: a possible mechanism altering the response to psychostimulants in female rats

2002 ◽  
Vol 100 (1-2) ◽  
pp. 75-83 ◽  
Author(s):  
Wenxia Zhou ◽  
Kathryn A. Cunningham ◽  
Mary L. Thomas
Author(s):  
Dan Ohtan Wang

Epitranscriptomics, a recently emerged field to investigate post-transcriptional regulation of gene expression through enzyme-mediated RNA modifications, is rapidly evolving and integrating with neuroscience. Using a rich repertoire of modified nucleosides and strategically positioning them to the functionally important and evolutionarily conserved regions of the RNA, epitranscriptomics dictates RNA-mediated cell function. The new field is quickly changing our view of the genetic geography in the brain during development and plasticity, impacting major functions from cortical neurogenesis, circadian rhythm, learning and memory, to reward, addiction, stress, stroke, and spinal injury, etc. Thus understanding the molecular components and operational rules of this pathway is becoming a key for us to decipher the genetic code for brain development, function, and disease. What RNA modifications are expressed in the brain? What RNAs carry them and rely on them for function? Are they dynamically regulated? How are they regulated and how do they contribute to gene expression regulation and brain function? This chapter summarizes recent advances that are beginning to answer these questions.


2018 ◽  
Vol 10 ◽  
pp. 117957351878746 ◽  
Author(s):  
Aino Vesikansa

The complex structure and highly variable gene expression profile of the brain makes it among the most challenging fields to study in both basic and translational biological research. Most of the brain diseases are multifactorial and despite the rapidly increasing genomic data, molecular pathways and causal links between genes and central nervous system (CNS) diseases are largely unknown. The advent of an easy and flexible CRISPR-Cas genome editing technology has rapidly revolutionized the field of functional genomics and opened unprecedented possibilities to dissect the mechanisms of CNS disease. CRISPR-Cas allows a plenitude of applications for both gene-focused and genome-wide approaches, ranging from original “gene scissors” making permanent modifications in the genome to the regulation of gene expression and epigenetics. CRISPR technology provides a unique opportunity to establish new cellular and animal models of CNS diseases and holds potential for breakthroughs in the CNS research and drug development.


2009 ◽  
Vol 303 (1-2) ◽  
pp. 25-33 ◽  
Author(s):  
Yewade Ng ◽  
Andrew Wolfe ◽  
Horacio J. Novaira ◽  
Sally Radovick

2016 ◽  
Vol 58 ◽  
pp. 42-49 ◽  
Author(s):  
Mario Alberto Burgos-Aceves ◽  
Amit Cohen ◽  
Yoav Smith ◽  
Caterina Faggio

1998 ◽  
Vol 65 (1-6) ◽  
pp. 253-272 ◽  
Author(s):  
Alejandro F. De Nicola ◽  
Monica Ferrini ◽  
Susana L. Gonzalez ◽  
Maria Claudia Gonzalez Deniselle ◽  
Claudia A. Grillo ◽  
...  

2019 ◽  
Author(s):  
Alexander J. Cammack ◽  
Arnav Moudgil ◽  
Tomas Lagunas ◽  
Michael J. Vasek ◽  
Mark Shabsovich ◽  
...  

AbstractTranscription factors (TFs) play a central role in the regulation of gene expression, controlling everything from cell fate decisions to activity dependent gene expression. However, widely-used methods for TF profiling in vivo (e.g. ChIP-seq) yield only an aggregated picture of TF binding across all cell types present within the harvested tissue; thus, it is challenging or impossible to determine how the same TF might bind different portions of the genome in different cell types, or even to identify its binding events at all in rare cell types in a complex tissue such as the brain. Here we present a versatile methodology, FLEX Calling Cards, for the mapping of TF occupancy in specific cell types from heterogenous tissues. In this method, the TF of interest is fused to a hyperactive piggyBac transposase (hypPB), and this bipartite gene is delivered, along with donor transposons, to mouse tissue via a Cre-dependent adeno-associated virus (AAV). The fusion protein is expressed in Cre-expressing cells where it inserts transposon “Calling Cards” near to TF binding sites. These transposons permanently mark TF binding events and can be mapped using high-throughput sequencing. Alternatively, unfused hypPB interacts with and records the binding of the super enhancer (SE)-associated bromodomain protein, Brd4. To demonstrate the FLEX Calling Card method, we first show that donor transposon and transposase constructs can be efficiently delivered to the postnatal day 1 (P1) mouse brain with AAV and that insertion profiles report TF occupancy. Then, using a Cre-dependent hypPB virus, we show utility of this tool in defining cell type-specific TF profiles in multiple cell types of the brain. This approach will enable important cell type-specific studies of TF-mediated gene regulation in the brain and will provide valuable insights into brain development, homeostasis, and disease.


1989 ◽  
Vol 3 (11) ◽  
pp. 1748-1756 ◽  
Author(s):  
Daniel Toranzo ◽  
Eric Dupont ◽  
Jacques Simard ◽  
Claude Labrie ◽  
Jacques Couet ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document